These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2652018)
1. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy. Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z Oncology; 1989; 46(2):105-8. PubMed ID: 2652018 [TBL] [Abstract][Full Text] [Related]
2. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459 [TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer. Silvey L; Carpenter JT; Wheeler RH; Lee J; Conolley C J Clin Oncol; 1988 Sep; 6(9):1397-400. PubMed ID: 3047334 [TBL] [Abstract][Full Text] [Related]
4. Pentobarbital's effect in a combination antiemetic regimen for cisplatin induced nausea and vomiting. Wheelock JB J Miss State Med Assoc; 1989 Jan; 30(1):5-8. PubMed ID: 2647995 [TBL] [Abstract][Full Text] [Related]
5. Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. Bishop JF; Olver IN; Wolf MM; Matthews JP; Long M; Bingham J; Hillcoat BL; Cooper IA J Clin Oncol; 1984 Jun; 2(6):691-5. PubMed ID: 6374058 [TBL] [Abstract][Full Text] [Related]
6. A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy. Bishop JF; Matthews JP; Wolf MM; Oliver IN; Reynolds S; Walpole E; Rischin D; Buchanan L; Tan LG Eur J Cancer; 1992; 28(1):47-50. PubMed ID: 1567690 [TBL] [Abstract][Full Text] [Related]
7. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy. Winokur SH; Baker JJ; Lokey JL; Price NA; Bowen J J Med Assoc Ga; 1981 Apr; 70(4):263-4. PubMed ID: 7012258 [No Abstract] [Full Text] [Related]
8. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807 [TBL] [Abstract][Full Text] [Related]
9. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine. Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843 [TBL] [Abstract][Full Text] [Related]
10. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine]. Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905 [TBL] [Abstract][Full Text] [Related]
11. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611 [TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis. Akhtar SS; Bano ZA; Bhat GM; Bhat MA Oncology; 1991; 48(3):226-9. PubMed ID: 2023702 [TBL] [Abstract][Full Text] [Related]
13. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. Orr LE; McKernan JF J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy. Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193 [TBL] [Abstract][Full Text] [Related]
15. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
16. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy. Lane M; Smith FE; Sullivan RA; Plasse TF Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391 [TBL] [Abstract][Full Text] [Related]
17. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone. Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784 [TBL] [Abstract][Full Text] [Related]
18. Adrenal corticosteroids as antiemetics during cancer chemotherapy. Cersosimo RJ; Karp DD Pharmacotherapy; 1986; 6(3):118-27. PubMed ID: 3526297 [TBL] [Abstract][Full Text] [Related]
19. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy. Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784 [TBL] [Abstract][Full Text] [Related]
20. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. Einhorn LH; Nagy C; Furnas B; Williams SD J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]